Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neostigmine and postoperative cognitive function in elderly noncardiac surgery
ChiCTR2100046248Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Dalian Medical University
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of neostigmine in post-operative cognitive decline (POCD) (2 arms), sponsored by The First Affiliated Hospital of Dalian Medical University. Primary endpoint: Postoperative cognitive dysfunction. Started May 2021; status: recruiting.
02
Drugs
neostigmine
03
Conditions
post-operative cognitive decline (POCD)
Beyond the preview
Go deeper on ChiCTR2100046248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100046248.